Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Antibodies against biotin-labeled red blood cells can shorten posttransfusion survival.
Journal: Transfusion
Published: October 22, 2021
Target-mediated disposition population pharmacokinetics model of erythropoietin in premature neonates following multiple intravenous and subcutaneous dosing regimens.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: April 09, 2019
Development, validation, and potential applications of biotinylated red blood cells for posttransfusion kinetics and other physiological studies: evidenced-based analysis and recommendations.
Journal: Transfusion
Published: December 05, 2017
Erratum: Leigh-Like Syndrome Due to Homoplasmic m.8993T>G Variant with Hypocitrullinemia and Unusual Biochemical Features Suggestive of Multiple Carboxylase Deficiency (MCD).
Journal: JIMD reports
Published: October 28, 2017
In premature infants there is no decrease in 24-hour posttransfusion allogeneic red blood cell recovery after 42 days of storage.
Journal: Transfusion
Published: June 12, 2017
Biotin: From Nutrition to Therapeutics.
Journal: The Journal of nutrition
Published: February 15, 2017
Antibodies to biotinylated red blood cells in adults and infants: improved detection, partial characterization, and dependence on red blood cell-biotin dose.
Journal: Transfusion
Published: November 10, 2016
Population Pharmacokinetics of Darbepoetin in Infants Following Single Intravenous and Subcutaneous Dosing.
Journal: Journal of pharmaceutical sciences
Published: October 24, 2016
Last Updated: 09/26/2026